Who
Megan C. Timmins
EVP, CLO & Secretary
Company insider
Files Form 4 as: EVP, CLO & Secretary, Rockwell Medical; SVP, Gen Csl & Sec, Assertio Holdings; General Counsel, Zyla Life Sciences.
In numbers
- Trades disclosed
- 43
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 6 Mar 2018
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Mar 2026filed 16 Mar 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $3,3003,667 at $0.90 | filing |
| 14 Mar 2026filed 16 Mar 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $3,3003,667 at $0.90 | filing |
| 20 May 2025filed 17 Apr 2026 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 20 May 2025filed 17 Apr 2026 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 17 Mar 2025filed 18 Mar 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $5,5523,137 at $1.77 | filing |
| 14 Mar 2025filed 18 Mar 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $6,2323,666 at $1.70 | filing |
| 17 Mar 2024filed 19 Mar 2024 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code F | $4,3923,137 at $1.40 | filing |
| 14 Mar 2024filed 15 Mar 2024 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —70,780 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 Mar 2023filed 21 Mar 2023 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —28,515 at $0.00 | filing |
| 9 Sep 2022filed 13 Sep 2022 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 17 Mar 2022filed 21 Mar 2023 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —37,210 at $0.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 20 May 2020filed 22 May 2020 | Assertio Holdingsoption or derivative | SEC FORM 4 Code A | —211,750 | filing |
| 20 May 2020filed 22 May 2020 | Assertio Holdings | SEC FORM 4 Code A | —190,480 | filing |
| 20 May 2020filed 21 May 2020 | Zyla Life Sciencesoption or derivative | SEC FORM 4 Code D | —84,700 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.